LSP HEF II is a venture capital fund focused on innovation and cost reduction in healthcare. EQT Life Sciences has more than 25 years of experience investing in this sector.
In 2022, EQT acquired private equity fund house Life Science Partners (LSP) and renamed it EQT Life Sciences.
LSP HEF II invests in companies specializing in medical devices, diagnostics and e-health that already have a product on the market or are close to market launch.
In doing so, the fund specifically targets companies that are developing innovations for a large population or that have the capacity to significantly reduce the cost of care.
The healthcare sector is an attractive sector to invest in, and investing in it helps improve the quality of healthcare.
The prospectuses of the closed end investment funds managed by IBS Fund Management B.V. and those of the underlying master investment funds are available to unitholders upon request (in the secure section of the site and at info@ibsfm.nl).
However, these prospectuses contain only limited information on sustainability, as the funds in question were closed before the Sustainable Finance Disclosure Regulation (“SFDR”) came into force and the SFDR could not yet be taken into account.
Prospectuses of closed end investment funds managed by IBS Fund Management B.V. with a closing date after March 10, 2021 do contain the information required by the SFDR.
